The D-Dimer test is a crucial diagnostic tool in haemostasis testing, widely used for the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE). It plays a vital role in identifying conditions related to excessive clot formation and fibrinolysis, offering clinicians an effective means to rule out serious thrombotic disorders.
This article explores the importance of the D-Dimer test, its diagnostic value, and how advanced reagents like Operon Biotech’s FibriLine D-Dimer improve accuracy and efficiency in clinical settings.
During blood coagulation, fibrinogen is converted into fibrin via thrombin activation. The fibrin forms a clot, stabilized by Factor XIII, creating an insoluble fibrin mesh. When the clot begins to degrade, the enzyme plasmin breaks down cross-linked fibrin, releasing D-Dimer fragments, which serve as biomarkers of clot formation and dissolution.
D-Dimer levels are thus an indicator of active thrombosis and fibrinolysis, making this test essential for diagnosing and monitoring coagulation disorders.
The D-Dimer assay is widely used to assess thrombotic conditions such as:
D-Dimer testing has a high negative predictive value (>95%), meaning a negative result effectively rules out thrombosis. However, due to low specificity, elevated D-Dimer levels may also be seen in conditions such as pregnancy, infections, cancer, and inflammation, necessitating further clinical correlation.
Studies show that combining the Wells Score (a clinical prediction tool) with D-Dimer testing improves diagnostic accuracy. In patients with a low Wells score and a negative D-Dimer result, DVT can be safely ruled out without further imaging.
Meta-analyses indicate that D-Dimer testing is more sensitive for proximal DVT than distal DVT. For suspected isolated distal deep vein thrombosis (IDDVT), D-Dimer alone may not be sufficient, and additional imaging is often required. The predictive negative value for IDDVT diagnosis varies, with some studies reporting <90%, while others suggest ≥97%.
The FibriLine D-Dimer reagent by Operon Biotech & Healthcare is a clinically proven, high-quality reagent designed for rapid and reliable DVT and PE exclusion. It is compatible with Operon’s automated coagulation analyzers (XL-1000C, XL-1000i, and XL-1000e), offering:
The Operon FibriLine D-Dimer Latex is a rapid agglutination assay utilizing latex beads coupled with a highly specific D-Dimer monoclonal antibody. Cross-linked fibrin degradation products (XL-FDP) in a plasma sample bind to the coated latex beads, causing visible agglutination when D-Dimer concentration surpasses the assay’s detection threshold.
The FibriLine D-Dimer kit includes:
A FibriLine D-Dimer calibrator is used for automated 5-dilution calibration Log-Log curve on Operon XL-1000 series instruments. Once calibrated, sample processing is as simple as performing a PT test. The system automates dilution, runs the assay, and provides a quantitative result in ~5 minutes, ensuring high reliability and accuracy. To further enhance confidence in reporting, running quality controls with every batch is recommended.
FibriLine D-Dimer testing is fully automated on the XL-1000 series coagulation analyzers, ensuring:
This automation minimizes human error, ensuring high reliability and reproducibility in thrombosis screening and exclusion testing.
The D-Dimer test is an indispensable tool in diagnosing and managing thrombotic conditions. When combined with clinical prediction models like the Wells Score, it enhances diagnostic accuracy, reducing unnecessary imaging.
However, D-Dimer alone does not exclude the presence of IDDVT in patients with a time of ≥4 days between symptom onset and testing. In moderate-risk patients, the negative predictive value may be lower, and further studies are needed to determine its diagnostic efficacy.
FibriLine D-Dimer by Operon Biotech provides a highly sensitive, reliable, and automated solution for laboratories, improving workflow efficiency and ensuring high-quality patient care.
For clinical laboratories aiming for efficiency, precision, and cost-effectiveness, adopting advanced D-Dimer testing solutions is a step toward better diagnostic outcomes and improved patient management.
About Operon Biotech: Operon Biotech and Healthcare is a professionally managed biomedical company dealing with quality Coagulation product ranges. With a market presence and expertise in coagulation devices. You can reach out to Operon Biotech team at info@operonbiotech.com or on +91-9008178817.
Disclaimer : This content may be copyright protected. Reproduction, modification, or use without prior written permission is prohibited.
Questions/ Feedback? We’d love to hear from you! Feel free to write to us on info@dfinebio.in or comment in the section below.
